Mavenclad | European Medicines Agency
https://www.ema.europa.eu/en/medicines/human/EPAR/mavenclad
Sep 17, 2018 · Mavenclad can only be obtained with a prescription and treatment must be started and supervised by a doctor experienced in treating multiple sclerosis. The dose depends on … Active substance: Cladribine Name: Mavenclad Agency product number: EMEA/H/C/004230 Therapeutic area (MeSH): Multiple Sclerosis
Active substance: Cladribine
Name: Mavenclad
Agency product number: EMEA/H/C/004230
Therapeutic area (MeSH): Multiple Sclerosis
DA: 34 PA: 11 MOZ Rank: 44